We review the identified citrullinated peptide epitopes that are proposed as disease markers, specifically recognized in certain human autoimmune disorders, and discuss the diagnostic features and potential therapeutic value of anti-citrullinated protein antibodies based on ongoing clinical trials.
Ver versión en caché